ATE247458T1 - NEW CONTROLLED RELEASE BEADS, A METHOD FOR THE PRODUCTION THEREOF AND THE MULTIPLE UNIT TYPE FORMULATION CONTAINING SAME - Google Patents

NEW CONTROLLED RELEASE BEADS, A METHOD FOR THE PRODUCTION THEREOF AND THE MULTIPLE UNIT TYPE FORMULATION CONTAINING SAME

Info

Publication number
ATE247458T1
ATE247458T1 AT99971702T AT99971702T ATE247458T1 AT E247458 T1 ATE247458 T1 AT E247458T1 AT 99971702 T AT99971702 T AT 99971702T AT 99971702 T AT99971702 T AT 99971702T AT E247458 T1 ATE247458 T1 AT E247458T1
Authority
AT
Austria
Prior art keywords
production
controlled release
formulation containing
unit type
multiple unit
Prior art date
Application number
AT99971702T
Other languages
German (de)
Inventor
Torkel Gren
Anders Ringberg
Martin Wikberg
Randy J Wald
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE247458(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/SE1999/001463 external-priority patent/WO2000012069A1/en
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of ATE247458T1 publication Critical patent/ATE247458T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99971702T 1998-11-11 1999-11-11 NEW CONTROLLED RELEASE BEADS, A METHOD FOR THE PRODUCTION THEREOF AND THE MULTIPLE UNIT TYPE FORMULATION CONTAINING SAME ATE247458T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803871A SE9803871D0 (en) 1998-11-11 1998-11-11 Therapeutic method and formulation
PCT/SE1999/001463 WO2000012069A1 (en) 1998-08-27 1999-08-26 Therapeutic formulation for administering tolterodine with controlled release
PCT/SE1999/002052 WO2000027364A1 (en) 1998-11-11 1999-11-11 New controlled release bead, a method of producing the same and multiple unit formulation comprising it

Publications (1)

Publication Number Publication Date
ATE247458T1 true ATE247458T1 (en) 2003-09-15

Family

ID=20413266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971702T ATE247458T1 (en) 1998-11-11 1999-11-11 NEW CONTROLLED RELEASE BEADS, A METHOD FOR THE PRODUCTION THEREOF AND THE MULTIPLE UNIT TYPE FORMULATION CONTAINING SAME

Country Status (40)

Country Link
US (1) US6911217B1 (en)
EP (1) EP1128819B1 (en)
JP (1) JP3616011B2 (en)
KR (1) KR100467384B1 (en)
CN (1) CN1169522C (en)
AP (1) AP1323A (en)
AR (1) AR027815A1 (en)
AT (1) ATE247458T1 (en)
AU (1) AU762410B2 (en)
BG (1) BG65149B1 (en)
BR (1) BRPI9915142B8 (en)
CA (1) CA2350061C (en)
CZ (1) CZ299582B6 (en)
DE (1) DE69910604T2 (en)
DK (1) DK1128819T3 (en)
EA (1) EA005074B1 (en)
EE (1) EE05232B1 (en)
ES (1) ES2204193T3 (en)
GE (1) GEP20022833B (en)
HK (1) HK1040917B (en)
HR (1) HRP20010333B1 (en)
HU (1) HU226582B1 (en)
ID (1) ID30039A (en)
IL (1) IL142809A0 (en)
IS (1) IS2370B (en)
MA (1) MA25325A1 (en)
MY (1) MY122195A (en)
NO (1) NO331399B1 (en)
NZ (1) NZ511430A (en)
OA (1) OA11673A (en)
PL (1) PL195780B1 (en)
PT (1) PT1128819E (en)
RS (1) RS49891B (en)
SE (1) SE9803871D0 (en)
SI (1) SI1128819T1 (en)
SK (1) SK284758B6 (en)
TW (2) TWI267385B (en)
UA (1) UA57165C2 (en)
WO (1) WO2000027364A1 (en)
ZA (1) ZA200103575B (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000515525A (en) * 1996-07-19 2000-11-21 アベーグ，グンナー S (-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
EE05191B1 (en) * 1999-11-11 2009-08-17 Pharmacia Ab A pharmaceutical composition comprising tolterodine and its use
MXPA05002302A (en) * 2002-08-28 2005-06-08 Pharmacia Corp Oral liquid tolterodine composition.
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
KR20050096147A (en) * 2003-01-22 2005-10-05 피저 헬스 에이비 Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
DE10315917A1 (en) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
ATE493981T1 (en) 2003-11-04 2011-01-15 Supernus Pharmaceuticals Inc ONCE DAILY DOSAGE FORMS OF TROSPIUM
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) † 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
CA2590556A1 (en) * 2005-01-10 2006-07-13 Teva Pharmaceutical Industries Ltd. Process for preparing tolterodine tartrate
BRPI0611492B1 (en) 2005-05-31 2021-10-13 Mars, Incorporated BIFIDOBACTERIA PROBIOTICS FELINE
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
DK2997953T3 (en) 2006-01-18 2019-04-15 Intec Pharma Ltd ADMINISTRATION ORAL ADMINISTRATION
ES2593047T3 (en) 2006-02-03 2016-12-05 Opko Renal, Llc Treatment of vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
KR100714058B1 (en) * 2006-02-06 2007-05-02 한국유나이티드제약 주식회사 Extended-releasing composition for oral administration of tolterodine l-tartrate and the process thereof
ATE536864T1 (en) * 2006-02-24 2011-12-15 Teva Pharma METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS AND METHOD FOR THE PRODUCTION THEREOF
CA2645940A1 (en) * 2006-03-21 2007-09-27 Teva Pharmaceutical Industries Ltd. Controlled release formulation of tolterodine
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
EP2007360B1 (en) * 2006-04-03 2014-11-26 Isa Odidi Controlled release delivery device comprising an organosol coat
WO2007122015A1 (en) * 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2007131804A1 (en) 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
ES2670029T3 (en) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D replenishment agent and vitamin D hormone replacement agent
JP2008007458A (en) * 2006-06-29 2008-01-17 Freunt Ind Co Ltd Core particle for layering and method for producing the same
EP2096923B1 (en) 2006-11-27 2014-01-22 H. Lundbeck A/S Heteroaryl amide derivatives
CN101711158A (en) 2007-02-01 2010-05-19 爱默思公司 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
EP2762132A1 (en) 2007-04-25 2014-08-06 Cytochroma Inc. Controlled Release 25-Hydroxyvitamin D
DK2148684T3 (en) 2007-04-25 2013-04-22 Cytochroma Inc Method of treating vitamin D insufficiency and deficiency
CL2008001970A1 (en) * 2007-07-03 2009-03-27 Synthon Bv Bead with a microcrystalline cellulose core, a water soluble coating with a vinyl pyrrolidine polymer, a layer with tolterodine and a binder, and a controlled release layer with a polyacrylate; process to prepare it; dosage form, useful in urinary disorders such as overactive bladder.
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) * 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
WO2009019599A2 (en) 2007-08-08 2009-02-12 Themis Laboratories Private Limited Extended release compositions comprising tolterodine
PL2187873T3 (en) 2007-08-13 2019-01-31 Abuse Deterrent Pharmaceutical Llc Abuse resistant drugs, method of use and method of making
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
CN106853250A (en) 2008-04-02 2017-06-16 赛特克罗公司 Method, composition, purposes and kit for vitamin D deficiency and associated disorders
WO2009140557A2 (en) * 2008-05-14 2009-11-19 Capricorn Pharma, Inc. Modified release tolterodine formulations
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
US9078830B2 (en) 2009-07-31 2015-07-14 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
PT2552484T (en) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Methods and compositions for reducing parathyroid levels
JO3112B1 (en) 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
MX350447B (en) 2010-03-29 2017-09-07 Ferring Bv A fast dissolving pharmaceutical composition.
AU2011245499B2 (en) 2010-04-30 2014-09-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120289560A1 (en) * 2011-05-10 2012-11-15 Theravida, Inc. Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (en) 2011-07-27 2012-06-29 Φαρματεν Αβεε, Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof
RU2633640C2 (en) 2011-09-16 2017-10-16 Ферринг Б.В. Quick-soluble pharmaceutical composition
BR112014007753B1 (en) * 2011-09-30 2021-07-06 Astellas Pharma Inc. granular pharmaceutical composition, formulation and method for production
US9999590B2 (en) 2012-07-12 2018-06-19 Ferring B.V. Diclofenac formulations
US20140093552A1 (en) * 2012-09-20 2014-04-03 Sks Ocular, Llc Multilayer Biodegradable Microparticles for Sustained Release of Therapeutic Agents
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
TW201422254A (en) * 2012-11-21 2014-06-16 Ferring Bv Composition for immediate and extended release
NZ629598A (en) * 2013-03-13 2016-10-28 Advanced Bionutrition Corp Stable bioactive substances and methods of making
US11571390B2 (en) 2013-03-15 2023-02-07 Othemo Life Sciences, Inc. Abuse deterrent compositions and methods of use
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
SG10201911274TA (en) 2014-08-07 2020-02-27 Opko Ireland Global Holdings Ltd Adjunctive therapy with 25-hydroxyvitamin d
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
CA2936741C (en) * 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
JP6924177B2 (en) * 2016-02-23 2021-08-25 ニプロ株式会社 Pharmaceutical composition particles and orally disintegrating preparation containing them
TWI747893B (en) 2016-03-28 2021-12-01 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 Methods of vitamin d treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (en) * 1981-03-19 1986-10-29 Pharmatec Spa CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN
JPH07107450A (en) 1993-10-08 1995-04-21 Hitachi Ltd Information communication equipment
JP3453186B2 (en) 1994-04-14 2003-10-06 共和薬品工業株式会社 Sustained-release microcapsules and method for producing the same
SE9402422D0 (en) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
JP2000515525A (en) 1996-07-19 2000-11-21 アベーグ，グンナー S (-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
AU762410B2 (en) 2003-06-26
PT1128819E (en) 2003-12-31
AP1323A (en) 2004-11-05
NZ511430A (en) 2003-05-30
EE05232B1 (en) 2009-12-15
HUP0105038A3 (en) 2006-07-28
US6911217B1 (en) 2005-06-28
HK1040917A1 (en) 2002-06-28
SK6252001A3 (en) 2002-01-07
DE69910604T2 (en) 2004-06-24
SK284758B6 (en) 2005-11-03
IS2370B (en) 2008-06-15
NO20012314L (en) 2001-07-09
KR20010075695A (en) 2001-08-09
DE69910604D1 (en) 2003-09-25
BR9915142A (en) 2001-08-07
JP3616011B2 (en) 2005-02-02
ID30039A (en) 2001-11-01
BRPI9915142B1 (en) 2015-08-25
GEP20022833B (en) 2002-11-25
CN1169522C (en) 2004-10-06
OA11673A (en) 2005-01-12
NO331399B1 (en) 2011-12-19
JP2003517446A (en) 2003-05-27
HU226582B1 (en) 2009-04-28
CZ299582B6 (en) 2008-09-10
YU33101A (en) 2003-10-31
BG65149B1 (en) 2007-04-30
CA2350061C (en) 2005-05-17
CA2350061A1 (en) 2000-05-18
MY122195A (en) 2006-03-31
EP1128819A1 (en) 2001-09-05
TWI267385B (en) 2006-12-01
PL195780B1 (en) 2007-10-31
TWI222879B (en) 2004-11-01
HK1040917B (en) 2005-05-27
BRPI9915142B8 (en) 2021-05-25
ES2204193T3 (en) 2004-04-16
HUP0105038A2 (en) 2002-06-29
RS49891B (en) 2008-08-07
ZA200103575B (en) 2002-05-03
UA57165C2 (en) 2003-06-16
EA200100538A1 (en) 2001-10-22
EE200100254A (en) 2002-12-16
EP1128819B1 (en) 2003-08-20
IS5936A (en) 2001-05-09
AR027815A1 (en) 2003-04-16
DK1128819T3 (en) 2003-12-01
KR100467384B1 (en) 2005-01-24
EA005074B1 (en) 2004-10-28
AP2001002166A0 (en) 2001-06-30
PL348612A1 (en) 2002-06-03
SE9803871D0 (en) 1998-11-11
BG105582A (en) 2001-12-29
HRP20010333A2 (en) 2003-04-30
IL142809A0 (en) 2002-03-10
AU1436600A (en) 2000-05-29
MA25325A1 (en) 2001-12-31
NO20012314D0 (en) 2001-05-10
CZ20011627A3 (en) 2001-10-17
WO2000027364A1 (en) 2000-05-18
SI1128819T1 (en) 2003-12-31
HRP20010333B1 (en) 2004-10-31
CN1326339A (en) 2001-12-12

Similar Documents

Publication Publication Date Title
ATE247458T1 (en) NEW CONTROLLED RELEASE BEADS, A METHOD FOR THE PRODUCTION THEREOF AND THE MULTIPLE UNIT TYPE FORMULATION CONTAINING SAME
DE69604218D1 (en) Printing materials, processes for their production and recording processes
ATE389388T1 (en) SUSTAINED RELEASE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
DE59809806D1 (en) CHEMICAL MICROACTORS AND METHOD FOR THE PRODUCTION THEREOF
DE69530989D1 (en) NEW PYRIMID DERIVATIVES AND METHOD FOR THEIR PRODUCTION
DE69611599D1 (en) SEMI-BAROMATIC POLYAMIDE COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
DE69402051D1 (en) HEAT EXCHANGE ELEMENT, METHOD AND DEVICE FOR PRODUCING THE SAME
ATE252542T1 (en) BENZENE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DE69800419D1 (en) Prolonged release capsule and process for its manufacture
ATE219069T1 (en) NEW ARYLGLYCINAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
ATE279506T1 (en) TABLETS AND METHOD FOR THE PRODUCTION THEREOF
ATE242762T1 (en) ACRYLONITRILE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PEST CONTROL AGENTS CONTAINING SAME
ATE177732T1 (en) BENZYLSULFIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PEST CONTROL AGENTS CONTAINING SAME
DE60013901D1 (en) PHOTOLITHOGRAPHIC METHOD, MASK BLanks AND METHOD FOR THE PRODUCTION THEREOF
DE60022660D1 (en) GAS-DENSED COATING COMPOSITION, METHOD FOR THE PRODUCTION THEREOF AND GAS-DENSED COATING FILM
DE69713845D1 (en) PRINTING DEVICE AND METHOD FOR THE PRODUCTION THEREOF
DE69732033D1 (en) POLYPROPYLENE COMPOSITION, METHOD FOR THE PRODUCTION THEREOF AND POLYMERIZATION CATALYST FOR IT
ATE234103T1 (en) SOLID, ORAL RIBAVIRIN DOSAGE FORMS AND METHOD FOR THE PRODUCTION THEREOF
DE69815501D1 (en) FLAT PRINT PLATE AND METHOD FOR THE PRODUCTION THEREOF
DE69739750D1 (en) NEW LACTOSAMINE OLIGOSACCHARIDES AND METHOD FOR THE PRODUCTION THEREOF
DE69513858D1 (en) A silacyclohexane compound, a process for its preparation and a liquid crystalline composition containing the same
DE69905983D1 (en) Photosensitive composition, process for its preparation and printing plate material
DE59506861D1 (en) Organic sulfur compounds, processes for their preparation and use thereof
AT399880B (en) NEW THIENOTHIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE69421182D1 (en) NEW CLATHRATE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND ANTI-ANTI-AGENT

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1128819

Country of ref document: EP